First Line Pazopanib in Poor Risk Patients With Metastatic Renal Cell Carcinoma (FLIPPER)

Sponsors and Collaborators
iOMEDICO AG
Glaxo SmithKline

Contact
Oliver Rieder, PhD
0049 761 15242 ext 0
info@iomedico.com

Principal Investigator
Michael Staehler, PD MD, Ludwig-Maximilians-Universität München, Klinikum Grosshadern

ClinicalTrials.gov Identifier
NCT01521715